Universe Pharmaceuticals Gross Profit Growth & History (UPC)
Universe Pharmaceuticals's gross profit was $6.30B for fiscal 2025.
View full Universe Pharmaceuticals company overviewUniverse Pharmaceuticals annual gross profit history
2019
2020
2021
2022
2023
2024
2025
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | $6.30B | $229.3M | +3.78% |
| 2024 | 2024-09-30 | $6.07B | $6.06B | +58764.01% |
| 2023 | 2023-09-30 | $10.3M | −$11.6M | −52.88% |
| 2022 | 2022-09-30 | $21.9M | −$3.4M | −13.56% |
| 2021 | 2021-09-30 | $25.3M | $11.2M | +79.70% |
| 2020 | 2020-09-30 | $14.1M | $686,335 | +5.12% |
| 2019 | 2019-09-30 | $13.4M | — | — |
Universe Pharmaceuticals gross profit trends
Over the last five fiscal years, Universe Pharmaceuticals's gross profit increased from $14.1M to $6.30B, a change of $6.29B.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Universe Pharmaceuticals source filings ↗